The evolution of HIV/AIDS Epidemic in Romania 31 December 2013
|
|
- Leo Daniel
- 5 years ago
- Views:
Transcription
1 The evolution of HIV/AIDS Epidemic in Romania 31 December 2013
2 The data is collected from the HIV/AIDS confirmation charts, sent by the nine Regional Centers for Evaluation and Monitoring of HIV/AIDS Data and further processed and elaborated by Compartment for Monitoring and Evaluation of HIV/AIDS data in Romania, in National Institute for Infectious Diseases Prof. Dr. Matei Bals
3 Romania December 2013: PLWHA ( cumulative total, since 1985). High rate of HIV incidence in children who were infected in the 1980s in Romania The maximum number of these patients recorded at the beginning of the 1990s ; >90%: sub-type F1. During the same period, HIV incidence rate among the adult population was low, with a slight increase afterwards due to unprotected heterosexual contact, the main route of transmission for the last decade. Currently, Romania has a large number of survivors in the age group, who belong to the cohort (>6000). A large number of PLWHA who receive specific ARV therapy in relation to the total number of infected persons (>8000 December 31, 2012 out of 9800 in active surveillance at1 December 2013). Source: Surveillance Report: HIV/AIDS Surveillance in Europe ECDC Stockholm Source: Compartment for Monitoring and Evaluation of HIV/AIDS Data in Romania INBI Prof.Dr.M.Balş
4
5
6 HIV subtype: F predominance, unique in Europe cohort children: homogenous F1 subtype of HIV Thomson and Najera, JID, 2007; Stanojevic et al. AIDS Rev 2011;
7 Phylogenetic analysis of HIV-1 subtype F1 isolates F= <1% HIV infections worldwide: Africa & South America Romanian F1 subtype: closely related to Angolan subtype distantly related to S America F1 F1 origin: Congo (DRC), around the late 1950s Guimaraes & al Retrovirology 2009
8 Ministry of Health National Institute for Infectious Diseases Prof. Dr. Matei Bals Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania General Data at 31 December 2013 TOTAL HIV/AIDS (CUMULATIVE ) OF WHICH: HIV/AIDS cases in children (0-14 years at date of diagnosis ) HIV/AIDS cases in adults (> 14 years at date of diagnosis) Total no. of AIDS deaths ( ) Out of records HIV/AIDS children + adults 621 Number of patients living with HIV/AIDS Total AIDS (Cumulative ) AIDS cases in children (0-14 years at date of diagnosis) AIDS cases in adults (> 14 years at date of diagnosis) Total HIV (Cumulative ) HIV cases in children (0-14 years at date of diagnosis) HIV cases in adults (> 14 years at date of diagnosis) New HIV/AIDS cases, diagnosed in New HIV cases 472 New AIDS cases 325 HIV/AIDS related deaths, confirmed by medical charts in
9 Distribution of ages Age at date of diagnosis Cumulative total Distribution by age of PLWHA
10 Kaplan-Meyer survival curve % of persons who deceased, survived, on average >50 months: 15% of persons who deceased survived, on average around 100 month; 10% of persons who deceased survived, on average, 100 months. Limitations: we excluded the periods with no treatment, ART schemes, duration of treatment. Average period of survival= 43,4 months (C.I.95% 42,1-44,6) Median period of survival for men=42,2 months (C.I.95% 40,6-43,8) Median period of survival for women=45,4 months (C.I.95% 43-47,2)
11 New HIV/AIDS Cases 1 JANUARY 31 DECEMBER 2013
12 Distribution of new HIV/AIDS cases by counties LEGEND CHILDREN (0-14 yrs) ADULTS (> 14 yrs)
13 Distribution of new HIV/AIDS cases by sex, 2013
14 Distribution of new HIV/AIDS cases by age group and sex, 2013
15 Distribution of new HIV/AIDS cases by route of transmission in children, Vertical Male female
16 Distribution of new HIV/AIDS cases by routes of transmission in adults, 2013
17 Tendencies in routes of transmission Romania Route of transmission 31 December December December December December December December 2013 Vertical 8 (2%) 7 (1%) 20 (4%) 25 (5%) 21 (3%) 21 (2,6%) 21 (2,64%) MSM IDU 14 (3%) 40 (8%) 44 (9%) 60 (11) 95 (13%) 89 (10,8%) 4 (1%) 3 (1%) 7 (1,4%) 14 (3%) 131 (18%) MSM/IDU 1 (<0,5%) 5 (1%) Heterosexual 352 (79%) 397 (76) 383 (77%) 399 (75%) 440 (61%) Unknown 67 (15%) 71 (14%) 43 (8,6%) 32 (6%) 28 (4%) 252 (30,6%) 6 (1%) 414 (50%) 39 (5%) 88 (11,04%) 233 (29,23%) 5 (0,63%) 435 (54,58%) 15 (1,88%) Total
18 Tendencies in the routes of transmission Romania Heterosexual IDUs
19 New HIV/AIDS cases (January-December 2013) through i.v. drug use, by age groups Age group Male Female Total yrs yrs yrs yrs yrs yrs Total
20 New cases of HIV/AIDS infection through i.v. drug use, by age groups, recorded in % 6% 2% 7% 15% 30% 29% yrs yrs yrs yrs yrs yrs. 50
21 Drugs used by HIV patients, diagnosed in 2013
22 Drugs declared by HIV/IDU patients, diagnosed in % 10% 3% 69% Heroine Heroine/Ethnobotanicals/Cocaine Heroine/Ethnobotanicals Ethnobotanicals
23 New HIV/AIDS cases (January-December 2013) through i.v. drug use, by counties County Male Female Total Arad 1 1 Argeş 1 1 Bucureşti Braşov 1 1 Brăila 1 1 Buzau 1 1 Constanţa 3 3 Giurgiu 1 1 Gorj 1 1 Hunedoara 1 1 Ialomita 4 4 Ilfov Mureş 1 1 Neamţ 2 2 Olt 1 1 Prahova Timiş 3 3 Tulcea 1 1 Vâlcea 2 2 Total
24 HBV, HCV, STDs in new HIV/AIDS cases through i.v. drug use Tested for Positive % AgHBs 3 1,24% VHC % AgHBs + VHC 29 12,03% STDs 34 14,10%
25 HIV/TB Co-infection in HIV/IDUs, diagnosed in 2013
26 I.V. drug users diagnosed HIV+ in 2013, previously tested before the current HIV positive test Year of previous testing No. of patients Total 53
27 New HIV/AIDS cases registered in the National Data Base: vs. New HIV/AIDS cases in IDUs registered in the National Data Base: Year Criterion Number of HIV cases TOTAL of which IDUs TOTAL of which IDUs TOTAL of which IDUs TOTAL of which IDUs TOTAL of which IDUs Number of AIDS cases Total number of HIV/AIDS cases
28 HIV prevalence in IDUs under treatment HIV/HCV Prevalence in IDUs under treatment HCV prevalence in IDUs under treatment Source: The evolution of the HIV/AIDS outbreak among IDUs in Romania. Andrei Botescu- Romanian National Antidrug Agency
29 HIV testing in IDUs performed by the Public Health Directions Year Negative tests Positive tests TOTAL % positive tests % % % % % % %
30 CD4 values in new HIV/AIDS cases at adults Total no. of cases: 776
31 CD4 values in new cases diagnosed in adults Male Female Total no. of cases: 550 Total no. of cases: 226
32 CD4 values in new HIV/AIDS cases at adults Total no. of new cases: 776
33 CD4 values in new HIV/AIDS cases at adults Male Female Total no. of cases: 550 Total no. of cases : 226
34 CD4 values in i.v. drug users vs. HIV/AIDS patients with different routes of transmission, 2013 IDUs Patients with different routes of HIV transmission
35 CD4 values in IDUs diagnosed with HIV/AIDS in 2013
36 CD4 values in IDUs vs. patients with different routes of HIV transmission, diagnosed in 2013 IDU Patients with different routes of transmission
37 CD4 values in IDUs diagnosed with HIV/AIDS in 2013
38 Viral load (VL) values for 2013 Total no. of cases in adults: 776 2% 3% 11% 11% 56% 6% 11% < > Under assessment Not assessed Sursa: Compartimentul pentru Monitorizarea şi Evaluarea Infecţiei HIV/SIDA în România INBI Prof.Dr.M.Balş
39 Viral load values in new cases at adults, diagnosed in 2013 Male Female Total no. of assessed cases: 174 Total no. of assessed cases: 89
40 Evolution of HIV/AIDS infection in Romania
41 AIDS incidence in adults and children ( ) Children 2013: 0,28/ Adults 2013: 1,74/
42 Distribution of AIDS cases by sex at 31 December 2013 (cumulative total )
43 Age groups and sex distribution of AIDS cases at 31 December 2013 (cumulative total )
44 Probable route of transmission in children with AIDS (0-14 years at date of diagnosis) 31 December 2013 (cumulative total ) *Persons who received blood transfusions at the end of the 1980s and beginning of 1990s. **Persons with repeated and/or parenteral treatments and admissions at the end 1980s and beginning of 1990s
45 Probable routes of transmission in adults diagnosed with AIDS (>14 years at date of diagnoses) at 31 December 2013 (cumulative total ) * Persons who received blood transfusions at the end of the 1980s and beginning of 1990s.
46 Distribution of AIDS cases in women, by age groups and year of diagnosis, between
47 HIV incidence in adults and children, ( ) Children 2013: 0,37/ Adults 2013: 2,54/
48 Distribution of HIV cases by sex at 31 December 2013 (cumulative total )
49 Distribution of HIV cases by sex and age groups (at date of diagnosis) at 31 December 2013 (cumulative total)
50 Probable route of transmission in children with HIV (0-14 years at date of diagnosis) at 31 December 2013 (cumulative total) *Persons who received blood transfusions at the end of the 1980s and beginning of 1990s. **Persons with repeated and/or parenteral treatments and admissions at the end 1980s and beginning of 1990s
51 Probable route of transmission in adults with HIV (>14 years at date of diagnosis) at 31 December 2013 (cumulative total) * Persons who received blood transfusions at the end of the 1980s and beginning of 1990s
52 Distribution of HIV cases in women, by year of dagnosis and age groups ( )
53 Distribution of PLWHA by age group and sex at 31 December 2013 (cumulative total ) Age group Male SEX Female TOTAL < 1 year yrs yrs yrs yrs yrs yrs yrs yrs yrs yrs yrs yrs and > TOTAL
54 HBV, HCV and HBC+HCV infections in children HIV
55 HBV, HCV and HBC+HCV infections in HIV+ adults No. cases Year of diagn. 0 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11 '12 13 VHB VHC VHB+VHC
56 AIDS defining illnesses 2013
57 Distribution of deaths cases by years
58 Mean period of survival (months) of PLWA, between BI-therapy Triple therapy
59 Mother to child transmission in Romania
60 HIV/AIDS in children with mother to child transmission
61 HIV/AIDS acquired through vertical transmission by age groups
62 Children 0-14 years: number of therapeutic regimens, prior to the current one: 31 December 2013
63 ARV schemes in children- 31 December 2013
64 Viral load in children under antiretroviral treatment
65 MTCT prophylaxis in pregnant women Total no. pregnant women Prophylaxis No prophylaxis
66 Prophylaxis of mother to child transmission in children to HIV positive mothers Year Number of newborns Number of prophylaxis
67 HIV testing 2013
68 *Data are sent by County Public Health Authorities HIV testing* in risk groups 2013 Risk groups Negative tests Positive tests TOTAL %positive STI ,71 TBC ,81 Maternity testing ,45 Pregnant women ,10 Health professionals ,00 Persons with hemodialysis ,00 Persons with transfusions ,00 Prenuptial check-up ,00 IDU ,75 Inmates ,47 MSM ,04 SWs ,86 HIV contacts ,24 Sailors ,02 Drivers ,17 Work abroad > 6 months ,58 Stay abroad > 6 months ,00 On request ,99 Occasional ,19 TOTAL ,74
69 HIV testing in pregnant women*, by age groups 2013 Age group Negative tests Positive tests TOTAL years years years years years years > 40 years Unspecified age TOTAL *Data are sent by County Public Health Authorities
70 HIV testing in pregnant women by age groups 2013
71 Total testing HIV testing in pregnant women Total testing Year
72 HIV testing in blood donors Year
73 HIV testing in STI patients Total tests Positive tests Year '00 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11 '12 '13 Total tests Positive tests Total tests Positive tests
74 HIV testing in TB patients Total tests Positive tests 2000 Year 0 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11 '12 ' Total tests Positive tests
75 HIV testing in HIV contacts Total tests Positive tests Year 0 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11 '12 '13 0 Total tests Positive tests
76 Source: Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania INBI Prof.Dr.M.Balş HIV testing on request Year
77 Challenges
78 Challenges of HIV/AIDS management in Romania Impact of therapeutic fatigue on adherence to antiretroviral therapy. Advanced stage of diseases+ virologic and immunologic failure. Multiple associated diseases that require specific treatment and antiretroviral treatment. Management: ART in TB/HIV co-infection ART în HIV, HBV/HCV co-infection New HIV-IDU cases (78% HC co-infection, 12% HBV-HCV coinfection, 14% STDs in 2013) Source: Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania INBI Prof.Dr.M.Balş
79 *National HIV/AIDS Strategy Challenges of HIV/AIDS management in Romania Most WLHA are long term survivors, infected at the end of the 1980s: Multiple therapeutic regimens- impact on ART resistance. ~50% of couples are serodiscordant (>50% women are HIV+). In this context, during the last few years the rate of MTCT has maintained a low value- <5%, due to the National Prevention Program of Mother to Child Transmission, established in In 2013 the rate represented 2,64% of the new reported cases. Further efforts are made to keep MTCT rate at low values.
80 Challenges of HIV/AIDS management in Romania During the last few years the main route of transmission has been heterosexual contact (unprotected)> in ,58% of the new cases. IDU/HIV increased: from 3% in 2010 to 329,23% in MSM/HIV has the same value: 11% of the new cases in The largest number of newly diagnosed cases has been recorded for the age group, 35% of these being late presenters. Increase in the number PLWHA whose state requires specialized medical care. Source: Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania INBI Prof.Dr.M.Balş
81 Challenges: 2013 PLWHA MTCT ART Use IDUs Young by age, old by treatment Therapeutic fatigue Young mothers, multi- experienced in ART Mothers with unknown HIV status- tested and treated for HIV Treatment as prevention Legal drugs Source : A. Streinu-Cercel. cnlas.ro: Specific Challenges of the Hiv Epidemic in Romania. EACS 2013.
82 cohort The largest cohort in Europe age group. It represents ~half of the HIV+ population in Romania Share by sexes: 1:1 F1 subtype: approximatively 100 % Long term survivors (~6000 survivors) Multiple ART regimens (10-15!) Salvage therapy ARV toxicity therapeutic fatigue They have/want children: problemes vertical transmission Long term teratogenic effects of ART Sourse: A. Streinu-Cercel. cnlas.ro: Specific Challenges of the Hiv Epidemic in Romania. EACS 2013.
83 New cases: Late presenters: heterosexual persons, F1 subtype Real time presenters: MSM&IDUs (primary HIV infection!): MSMs: high level of education voluntary and pro-active IDUs: socially integrated tested by the healthcare professionals in the system Transmitted resistance: low levels in all groups <10% (4.6%) An important problem: children to mothers who inject drugs, which represents a risk of HIV+HCV+HBV co-infections! Source : A. Streinu-Cercel. cnlas.ro: Specific Challenges of the Hiv Epidemic in Romania. EACS 2013.
84 HIV/AIDS infection in the world 2012
85 General data on HIV/AIDS in the world December 2012 Source: UNAIDS Global Report Epidemiology September 2013 Total 35,3 million (32,2 38,8 million) PLWHA Persons infected with HIV in 2012 Adults Women Children < 15 years Total Adults 32,1 million (29,1 35,3 million) 17,7 million (16,4 19,3 million) 3,3 million (3,0 3,7 million) 2,3 million (1,9 3,7 million) 2,0 million (1,7 2,4 million) Children < 15 years ( ) AIDS deaths in 2012 Total Adults 1,6 million(1,4 1,9 million) 1,4 million (1,2 1,7 million) Children < 15 ani ( )
86 million Source: UNAIDS Global Report Epidemiology September 2013 Estimates on the numbers of PLWHA
87 Source: UNAIDS Global Report Epidemiology September 2013 Global estimates for adults and children December 2012 PLWH: 35,3 million (32,2 38,8 million) New cases of HIV cases in ,3 million (1,9 3,7 million) Deaths caused by AIDS in ,6 million (1,4 1,9 million)
88 Estimates on the number of living children and adults with HIV infection at the end of 2012 Source: UNAIDS Global Report Epidemiology September 2013
89 Estimates on the number of adults and children infected with HIV in 2012 Suource: UNAIDS Global Report Epidemiology September 2013
90 Estimates on the number of deaths caused by AIDS (adults and children) in 2012 Source: UNAIDS Global Report Epidemiology September 2013
91 Source: UNAIDS Global Report Epidemiology September 2013 Approximately 6300 persons have been infected with HIV, daily in 2012 Over 95% come from poor and developing countries. Almost 400 are children, with ages <15 years. Almost 5500 are persons between years, of whom: ~47% are women ~39% are between years
92 Source: UNAIDS Global Report Epidemiology September 2013 Global estimates on HIV and AIDS at the end of 2012 Children (<15 years) Children LWHA 3,3 million (3,1 3,8 million) Newly infected children in ( ) Deaths caused by AIDS in ( )
93 Source: UNAIDS Global Report Epidemiology September 2013 Statistical data by regions December 2012
94 HIV/AIDS estimates within the WHO Region (53 countries) Reported cases of HIV/AIDS (cumulative total): AIDS cases: AIDS deaths: HIV infection: Source: HIV surveillance Report 2012
95 Characteristics of HIV cases, diagnosed in the WHO European Region, by geographical areas WHO European Region West Centre East EU/EEA Countries Reporting countries/number 51/53 23/23 15/15 13/15 30/31 Number of HIV cases Rate/ population 7,8 6,6 1,9 22 5,8 % of cases: age group 10,3% 9,8% 15,4% 10,1% 10,6% Men/women ratio 2,1 3,1 4,5 1,4 3,2 Route of transmission Heterosexual 45,6% 35,3% 24,6% 60,2% 33,8% MSM 22,8% 41,7% 26,3% 1,2% 40,4% IV Drugs 17,8% 5,1% 7,4% 33,6% 6,1% Unknown 12,3% 17% 36,9% 3,2% 18,7% No data: Liechtenstein, Rusisa şand Uzbekistan; Countries that did not report age groups and routes of transmission are excluded *includes persons(12%) coming from Sub-Saharan African Countries; Source: HIV/AIDS surveillance Report 2012
96 Case definition: CDC&ECDC Stockholm This section contains the case definitions* for Acquired Immunodeficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) Infection *Source: Commission Decision of 28/IV/2008 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council Clinical Criteria (AIDS) Any person who has any of the clinical conditions as defined in the European AIDS case definition for: Adults and adolescents > 13 years [1] Children < 13 years of age [2] Laboratory Criteria (HIV) Adults, adolescents and children aged = 18 months At least one of the following three: Positive result of a HIV screening antibody test or a combined screening test (HIV antibody and HIV p24 antigen) confirmed by a more specific antibody test (e.g. Western blot) Positive result of 2 EIA antibody test confirmed by a positive result of a further EIA test Positive results on two separate specimens from at least one of the following three: Detection of HIV nucleic acid (HIV-RNA, HIV-DNA) Demonstration of HIV by HIV p24 antigen test, including neutralisation assay Isolation of HIV
97 Children aged <18 months Positive results on two separate specimens (excluding cord blood) from at least one of the following three: Isolation of HIV Detection of HIV nucleic acid (HIV-RNA, HIV-DNA) Demonstration of HIV by HIV p24 antigen test, including neutralisation assay in a child =1 month of age Epidemiological Criteria NA Case Classification A. Possible case NA B. Probable case NA C. Confirmed case HIV infection Any person meeting the laboratory criteria for HIV infection AIDS Any person meeting the clinical criteria for AIDS and the laboratory criteria for HIV infection
98 Definitions Incidence = number of new cases x /population, registered at 1 July Prevalence = number of new and old cases x /population registered at 1 July Child = individual entering the 0-14 age group, according to CDC definition ( ). Adult = individual over 15 years, according to CDC definition ( ).
99 *Sources Revised surveillance Case Definition for HIV Infection Among Adults, Adolescents, and Children Aged < 18 Month sand for HIV Infection and AIDS Among Children Aged 18 Months to <13 years--- CDC, United States, Commission Decision of 28/IV/2008 amending Decision 2002/253/Ec laying down case definitions for reporting communicable diseases to the Community network under Decision no 2119/98/EC of the European Parliament and Council Who case definitions of HIV for surveillance and Revised clinical staging and immunological Classification of HIV-related disease in adults and Children (World Health Organization 2007)
100 Manager: Prof.Dr. Adrian Streinu-Cercel Head of Infectious Diseases UMF Carol Davila President of National Committee to Fight AIDS& Infectious Diseases Committee Coordinator: Coordinator Adults Programme: CoordInator Children Programme: Mariana Mărdărescu MD PhD Lecturer Dr.Elisabeta Otilia Benea Dr. Sorin Petrea Statistical data operators : PC Operators: Epidemiology: As.med. Marieta Iancu Daniela Viţelaru Sanda Vintilă Dr. Ionel Iosif
The evolution of HIV/AIDS infection in Romania 31 December 2017
The evolution of HIV/AIDS infection in Romania 31 December 2017 The data is collected from the HIV/AIDS confirmation charts, sent by the nine Regional Centers for Evaluation and Monitoring of HIV/AIDS
More informationHIV/AIDS infection in Romania 30 June 2018
HIV/AIDS infection in Romania 30 June 2018 The data is collected from the HIV/AIDS confirmation charts, sent by the nine Regional Centers for Evaluation and Monitoring of HIV/AIDS Data and further processed
More informationQuality of medical services and their impact on the cascade of cares in HIV infection, at national level Roundtable discussion
Quality of medical services and their impact on the cascade of cares in HIV infection, at national level Roundtable discussion Mariana Mărdărescu MD PhD Adrian Streinu-Cercel MD PhD HC Mike Youle MD PhD
More informationROMANIA. HIV/AIDS statistical data 30 June 2013
ROMANIA HIV/AIDS statistical data 30 June 2013 The following information are the synthesis of a collecting process based on HIV/AIDS charts, delivered by nine Regional HIV Centers and Compartment for Monitoring
More informationSTRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA
STRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA Simona Claudia CAMBREA MD, Ph D Faculty of Medicine, Ovidius University, Constanta, Romania Clinical Infectious
More information30 years of HIV experience in Romania
30 years of HIV experience in Romania UNAIDS objectives Source: http://www.unaids.org/sites/default/files/media_asset/jc2686_wad2014report_en.pdf Europe 2013 Geographical/epidemiological division of the
More informationHIV and Paediatrics in Central Europe
2nd Central and Eastern European Meeting on Viral Hepatitis and Co-Infection with HIV HIV and Paediatrics in Central Europe Mariana Mărdărescu MD PhD Consultant in Infectious Diseases Senior Doctor in
More informationHIV infection in children. Mariana Mardarescu MD PhD,
HIV infection in children Mariana Mardarescu MD PhD, Paediatric and Adolescents Immunodepression Department National Institute for Infectious Diseases Prof. Dr. Matei Bals, Bucharest A child is not a miniature
More informationHepatitis C Burden in Romania Evaluation 2018 Challenges Prof. Adrian Streinu-Cercel MD, PhD, HC
Hepatitis C Burden in Romania 2016-2017 Evaluation 2018 Challenges Prof. Adrian Streinu-Cercel MD, PhD, HC Carol Davila University of Medicine and Pharmacy National Institute For Infectious Diseases, Prof.
More informationModule 1: HIV epidemiology, transmission and prevention
Session 1 Module goals Module 1 Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches
More informationScaling up priority HIV/AIDS interventions in the health sector
TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June
More informationEDMA HIV-AIDS TEAM Fact Sheet November 2007
EDMA HIV-AIDS TEAM Fact Sheet November 2007 1. HIV Facts AIDS epidemic update UNAIDS Epidemic Update, November 2007 (1) 760,000 people to be living with HIV in Western and Central Europe in 2007. 31,000
More informationProgram to control HIV/AIDS
90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,
More informationHIV-HBV coinfection in HIV population horizontally infected in early childhood between
UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE HIV-HBV coinfection in HIV population horizontally infected in early childhood between 1987-1990 Supervising professor: Prof. Cupşa Augustin
More informationTrends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University
Trends in HIV/AIDS epidemic in Asia, and its challenge Taro Yamamoto Institute of Tropical Medicine Nagasaki University Millennium Development Goals Goal 1. Eradicate extreme poverty and hunger Goal 2.
More informationROMANIA. Country Progress Report on AIDS Reporting period January 2014 December 2014
ROMANIA Country Progress Report on AIDS Reporting period January 2014 December 2014 Bucharest, 2015 1 Contents Abbreviations... 3 I. Status at a glance... 4 a) Inclusiveness of stakeholders in the report-writing
More informationHIV-1 Subtypes Circulating in Constanta
ARS Medica Tomitana - 2017; 4(23): 163-169 10.1515/arsm-2017-0030 Cernat Roxana-Carmen1, Dumitru Irina Magdalena1, 2, Oțelea D.3, Rugină S. 1,2,4,5 HIV-1 Subtypes Circulating in Constanta 1 Clinical Hospital
More informationAnnual Epidemiological Report
November 2018 Annual Epidemiological Report 1 HIV in Ireland, 2017 Key Facts There were 492 diagnoses of HIV notified in 2017, a rate of 10.3 per 100,000 population. The HIV rate in Ireland has been relatively
More informationThresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016
Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016 1 Objectives of today s lecture Describe global goals in the fight against HIV Review the epidemiology
More informationMinutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg
EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C4 - Health determinants Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012,
More informationPaediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff
Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme- 20171031[2].tiff Mo Archary King Edward VIII Hospital / UKZN Paediatric Infectious Diseases Unit Overview State
More informationHIV EPIDEMIC UPDATE: FACTS & FIGURES 2012
HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a
More informationECDC s role in the fight against HIV/AIDS in Europe
European Centre for Disease Prevention and Control ECDC s role in the fight against HIV/AIDS in Europe Marita van de Laar, PhD Program Coordinator HIV/AIDS, STI, hepatitis HIV in Europe, Stockholm, 2 November
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More informationGLOBAL AIDS MONITORING REPORT
KINGDOM OF SAUDI ARABIA MINISTRY OF HEALTH GLOBAL AIDS MONITORING REPORT COUNTRY PROGRESS REPORT 2017 KINGDOM OF SAUDI ARABIA Submission date: March 29, 2018 1 Overview The Global AIDS Monitoring 2017
More informationKey issues for HIV testing and
Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics
More informationECDC and Spanish Ministry of Health workshop:
ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,
More informationTreat All : From Policy to Action - What will it take?
Strategy Finance Integration Cascade of services People centred Political Will Treat All : From Policy to Action - What will it take? Thursday, 9 June, 13.00 14.30 Conference Room 11, United Nations Questions
More informationThe evolution of the HIV/AIDS outbreak among IDUs in Romania
The evolution of the HIV/AIDS outbreak among IDUs in Romania Romanian National Antidrug Agency Romanian National Focal Point on Drugs Andrei Botescu * Lisbon, 12 th October 2012 HIV outbreak among IDU
More informationScreening programmes for Hepatitis B/C in Europe
Programme STI, HIV/AIDS and viral hepatitis Screening programmes for Hepatitis B/C in Europe Mika Salminen, Ph.D. European Centre for Disease Prevention and Control Why might screening be needed for hepatitis
More informationPREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County
PREVENTION OF HIV IN THE TIMES OF PREP Daniela Chiriboga, MD Florida Department of Health in Polk County MAKING THE CASE FOR PREVENTION The Epidemic in Florida Population in 2014: 19.6 million (3 rd in
More informationAIDS was described in June 1981 among homosexuals in the USA, and the virus. HIV/AIDS epidemic features and trends in Saudi Arabia
ORIGINAL ARTICLE HIV/AIDS epidemic features and trends in Saudi Arabia Yagob Y. Al-Mazrou, PhD, FRCGP; Mohamed H. Al-Jeffri, MSc, DTM&H; Abdulla Ibrahim Fidail, DPH, MPH; Nasir Al-Huzaim, MPH, PhD; Sirrag
More informationAIDS Acquired Immune Deficiency Syndrom
HIV and AIDS World, Europe and Poland Dorota Chrominska-Szosland MD, PhD Nofer Institute of Occupational Medicine Lodz-Poland HIV Human Immunodeficiency Virus AIDS Acquired Immune Deficiency Syndrom 1
More information2 nd Meeting on detecting and responding to outbreaks of HIV among PWID
2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: ROMANIA Adrian Abagiu* & Andrei Botescu** *Romanian Association Against AIDS (ARAS) and National Institute
More informationHIV Lecture. Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital
HIV Lecture Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital End-2001 global estimates for children and adults People living with HIV/AIDS New HIV infections in
More informationViral Hepatitis Burden and Policy Directions in the European Region of WHO
Viral Hepatitis Burden and Policy Directions in the European Region of WHO Dr Nedret Emiroglu WHO Regional Office for Europe Brussels 14-15 October 2010 Global Burden of Chronic Viral Hepatitis 2.7% all
More informationECDC update to the EU Commission Think Tank on HIV/AIDS
ECDC update to the EU Commission Think Tank on HIV/AIDS Andrew Amato Head of HIV, STI and V. Hepatitis programme, ECDC Luxembourg, 10-11 December 2013 Outline Main ECDC reports published since last Think
More informationTunisian recommendations on ART : process and results
Second Arab Congress of Clinical Microbiology and Infectious Diseases May 24-26, 2012. Tunisian recommendations on ART : process and results M. BEN MAMOU UNAIDS Email: BenmamouM@unaids.org M. CHAKROUN
More informationMonitoring Recent HIV Infection in Ireland, 2017
Monitoring Recent HIV Infection in Ireland, 2017 January 2019 Key Facts 1 13% of HIV diagnoses in 2017 (of those tested) were likely to be recent infections (within 4 months), using the Recent Infection
More informationMid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006
Mid-term Review of the UNGASS Declaration of Commitment on HIV/AIDS Ireland 2006 Irish Role in Global Response Just as the HIV/AIDS epidemic is a global threat, addressing the challenge of the epidemic
More informationHIV & AIDS IN SOUTH AFRICA: WHERE ARE WE AND WHAT ARE
HIV & AIDS IN SOUTH AFRICA: WHERE ARE WE AND WHAT ARE THE REMAINING CHALLENGES DR YOGAN PILLAY, NDOH SA HIV CLINICIANS SOCIETY CONFERENCE, CAPE TOWN 25 NOVEMBER, 2012 GLOBAL DATA 34m people living with
More informationHIV Testing. ECHO Hep C. Judith Feinberg, MD June 22, 2017
HIV Testing ECHO Hep C Judith Feinberg, MD June 22, 2017 Overview A few basics HIV epidemiology in the US HIV testing Time course of HIV-1 infection symptoms HIV proviral DNA symptoms window period HIV
More informationSex Work in Sub-Saharan Africa : Opportunities and Challenges
Sex Work in Sub-Saharan Africa : Opportunities and Challenges Dr Traore Isidore May 26, 2016 Definition of Sex Worker Female, male and transgender adults (18 years of age and above) who receive money or
More informationLinkages between Sexual and Reproductive Health and HIV
Linkages between Sexual and Reproductive Health and HIV Manjula Lusti-Narasimhan Department of Reproductive Health and Research World Health Organization The HIV pandemic 25 years 1981 2006 Rationale for
More informationOutline. AIDS & HIV in the Travis County. Global estimates for adults & children end HIV incidence worldwide
Outline AIDS & HIV in the Joshua Vest Epidemiologist Austin/ Health & Human Services Department Worldwide HIV/AIDS surveillance National Prevalence Trends Disparities Mortality Modes of exposure Risk factors
More informationWhen PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London
When PrEP fails Laura Waters MD FRCP Mortimer Market Centre London www.aidsunited.org PrEP works If people at risk take it If it s taken in the right way If it s available Commissioned/licensed Affordable
More informationSeble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University
Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University November 5, 2016 None HIV epidemiology Global U.S. Washington, D.C.
More informationHIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016
HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016 1 Thus the HIV DR needs to focus on prevention and then diagnostic capacity to 1 st provide VL monitoring for early &
More informationELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD
ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD 17 May 2018 Bucharest, Romania Organisers Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe
More informationHIV AND HEPATITIS B/C CO-INFECTION IN KWAZULU-NATAL FROM 2002 TO 2010: A RETROSPECTIVE DATABASE ANALYSIS
HIV AND HEPATITIS B/C CO-INFECTION IN KWAZULU-NATAL FROM 2002 TO 2010: A RETROSPECTIVE DATABASE ANALYSIS Submitted to: SCHOOL OF NURSING AND PUBLIC HEALTH UNIVERSITY OF KWAZULU-NATAL DURBAN SOUTH AFRICA
More informationHIV AND AIDS FACT SHEETS
The Human Immunodeficiency Virus (HIV) has been one of the most devastating new diseases to emerge over the course of the past century. Even though HIV may not always be in the headlines now, it is still
More informationImproving accessibility to antiretroviral drugs: A south-south collaboration
Improving accessibility to antiretroviral drugs: A south-south collaboration Jaideep A Gogtay MD Cipla Ltd Mumbai jgogtay@cipla.com Adults and children estimated to be living with HIV at the end of 2000
More informationEpidemiological Characteristics of HIV/AIDS Pandemic in Romania
[ Applied Medical Informatics Original Research Vol. 27, No. 4/2010, pp: 31-38 Epidemiological Characteristics of HIV/AIDS Pandemic in Corina-Liana MANIU *, Andrei ACHIMAŞ CADARIU Iuliu Haţieganu University
More informationRoche to provide HIV diagnostic solutions to Global Fund. Framework agreement with Global Fund strengthens access to HIV diagnostics
Media Release June 18, 2015 Roche to provide HIV diagnostic solutions to Global Fund Framework agreement with Global Fund strengthens access to HIV diagnostics Roche (SIX: RO, ROG; OTCQX: RHHBY) announced
More informationWho is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers
HIV and migrants Julia del Amo has received research grants awarded to her institution from Companies BMS, Gilead, ViiV and epidemiology teaching fees from ViiV, Gilead and MSD Dr Julia del Amo National
More informationIntensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite
Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Riga East Clinical hospital, Centre for tuberculosis and lung diseases. Head of outpatient department.
More informationOkinawa, Toyako, and Beyond: Progress on Health and Development
Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,
More informationFertility Desires/Management of Serodiscordant HIV + Couples
Fertility Desires/Management of Serodiscordant HIV + Couples William R. Short, MD, MPH Assistant Professor of Medicine Division Of Infectious Diseases Jefferson Medical College of Thomas Jefferson University
More informationVersion for the Silent Procedure 29 April Agenda item January Hepatitis
Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh
More informationHEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38
2016 Annual Morbidity Report HEPATITIS C, ACUTE a Rates calculated based on less than 19 cases or events are considered unreliable b Calculated from: CDC. Notice to Readers: Final 2016 Reports of Nationally
More informationHIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital
HIV-1 Subtypes: An Overview Anna Maria Geretti Royal Free Hospital Group M Subtypes A (1, 2, 3) B C D F (1, 2) G H J K Mechanisms of HIV-1 genetic diversification Point mutations RT error rate: ~1 per
More informationViral Hepatitis in Ireland, 2005
Viral Hepatitis in Ireland, 25 Key Points Hepatitis A incidence remained low, with 56 cases notified in 25 The number of hepatitis B notifications continued to increase with 95 cases reported in 25, compared
More informationThe outlook for hundreds of thousands adolescents is bleak.
Adolescents & AIDS Dr. Chewe Luo Chief HIV/AIDS, UNICEF Associate Director, Programmes Division 28/11/17 Professor Father Micheal Kelly Annual Lecture on HIV/AIDS Dublin, Ireland The outlook for hundreds
More informationClinical and Public Health Policy Implications of Findings that:
Clinical and Public Health Policy Implications of Findings that: Adherence to HIV Medications and Emotional/Physiological Coping with Stress are Independently Associated with Specific Five-Year Outcome
More informationElimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014
Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Outline Background History of prevention of mother to child
More informationVI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology
VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology HIV stands for human immunodeficiency virus. If left untreated, HIV can lead to the disease AIDS (acquired immunodeficiency syndrome).
More informationHIV/AIDS Epidemiology in Alameda County: State of the County Report
Lake Merritt, Oakland,California HIV/AIDS Epidemiology in Alameda County: State of the County Report Muntu Davis, MD, MPH County Health Officer and Public Health Director Alameda County White House Office
More informationSTI and HIV Prevention and Care among Sex Workers
Training Course in Sexual and Reproductive Health Research 2017 Module: Sexually transmitted infections, HIV/AIDS STI and HIV Prevention and Care among Sex Workers Annette Verster and Michelle Rodolph
More informationSTD & HIV ANNUAL REPORT. An Annual Review of HIV and STD s reported in Oakland County, Michigan
STD & HIV ANNUAL REPORT 2016 An Annual Review of HIV and STD s reported in Oakland County, Michigan Similar to numbers reported statewide, Oakland County saw an increase in the number of reported cases
More informationIFMSA Policy Statement Ending AIDS by 2030
IFMSA Policy Statement Ending AIDS by 2030 Proposed by IFMSA Team of Officials Puebla, Mexico, August 2016 Summary IFMSA currently acknowledges the HIV epidemic as a major threat, which needs to be tackled
More informationIntegration of collaborative TB/HIV activities with harm reduction services
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases control, Head of Department on HIV/AIDS combating
More informationAssessment of G8 Commitments on Maternal, Newborn and Child Health
Assessment of G8 Commitments on Maternal, Newborn and Child Health Robin Lennox Researcher, G8 Research Group June 13, 2010 In January 2010, Canadian prime minister Stephen Harper announced that maternal,
More informationColloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention
Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness
More informationConcept note. 1. Background and rationale
Concept note Inter-Country Workshops for Strengthening Regional and National Human Capacity to Accelerate Scaling up of National PMTCT and Paediatric Care, Support and Treatment Programmes TOWARDS UNIVERSAL
More informationMissouri St. Louis TGA 2016 HIV Epidemiological Profile
Missouri St. Louis TGA 2016 HIV Epidemiological Profile St. Louis TGA Part A Planning Council Prepared by the City of St. Louis Department of Health Center for Health Information, Research, and Planning
More informationHIV/AIDS MODULE. Rationale
HIV/AIDS MODULE Rationale According to WHO HIV/AIDS remains one of the world's most significant public health challenges, particularly in low- and middle-income countries. As a result of recent advances
More informationSouth Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018
South Africa s National HIV Programme Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH 23 October 2018 Overview The HIV and AIDS sub-programme at NDOH is responsible for: policy formulation, coordination,
More informationProgress against the HIV Epidemic: is the end in sight?
Progress against the HIV Epidemic: is the end in sight? Christine Hughes, BscPharm, PharmD, FCSHP Professor, Faculty of Pharmacy & Pharmaceutical Sciences University of Alberta Clinical Pharmacist, Northern
More informationGovernment of Canada Federal AIDS Initiative Milestones
HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for
More informationHIV/Hepatitis co-infection situation in Romania. Oana Săndulescu, MD, PhD
HIV/Hepatitis co-infection situation in Oana Săndulescu, MD, PhD Carol Davila University of Medicine and Pharmacy National Institute of Infectious Diseases Prof. Dr. Matei Balș Bucharest, Disclosures Carol
More informationMariza Vono Tancredi. Eliseu Alves Waldman
Mariza Vono Tancredi Eliseu Alves Waldman RATIONALE The clinical and laboratorial data from a population at a STD/AIDS Referral and Training Center (CRT) in Sao Paulo, Brazil, with 7,853 HIV infected individuals
More informationHuman Immunodeficiency Virus
Human Immunodeficiency Virus Isolated in 1983 by Luc Montagnier & Robert Gallo, separately. Genetic material is RNA Carries reverse transcriptase, an enzyme that makes DNA out of RNA in the host cell Cells
More informationTOWARDS UNIVERSAL ACCESS
At a glance TOWARDS UNIVERSAL ACCESS Scaling up priority HIV/AIDS interventions in the health sector June 2008 Progress Report This document represents material excerpted from Towards universal access:
More information15 years Follow Up in a Cohort of Children diagnosed with HIV Cardiomyopathy
15 years Follow Up in a Cohort of Children diagnosed with HIV Cardiomyopathy Lecturer Ana Maria TudorMD PhD * Mariana Mărdărescu MD PhD * Professor Ioana Anca MD PhD * * National Institute for Infectious
More informationHepatitis C. Core slides
Hepatitis C Core slides This material was prepared by the Viral Hepatitis Prevention Board The slides (or subsets) can be reproduced for educational use only, with reference to the original source and
More informationIntegrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China
Integrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China China presentation Wang Linhong MD, Professor National Center of MCH, China CDC 1 HIV/AIDS
More informationThe current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint
The current status of PrEP in Europe Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint DISCLOSURES I have received a research grant from Gilead Sciences awarded to my institution
More informationIntegration of recent infection monitoring into national HIV surveillance: 2016 results January 2018
Integration of recent infection monitoring into national HIV surveillance: 2016 results January 2018 Key Points In this pilot study, 13% of HIV diagnoses in 2016 were likely to be recent infections (within
More informationHIV/AIDS in China. -A A Potential epidemic? Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA
HIV/AIDS in China -A A Potential epidemic? Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA September 12, 2008 1 HIV epidemic in Asia General Population
More informationHIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP
HIV: Pregnancy in Serodiscordant Couple Dr Chow TS ID Clinic HPP Sexual Reproductive Health and Rights The recognition of the sexual and reproductive health and rights (SRHR) of all individuals and couples
More informationHIV and PEP. LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED
HIV and PEP LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED Disclaimer The views expressed in this presentation are those of the speaker and do not reflect the official policy of the Department
More informationMetro St. Louis HIV Epidemiological Profile
Metro St. Louis HIV Epidemiological Profile Saint Louis TGA Part A Planning Council Prepared by the City of St. Louis Department of Health s Center for Health Information, Research, and Planning Table
More informationThe effect of lamivudine- versus tenofovir-containing antiretroviral regimen on hepatitis B infection in a cohort of HIV infected long term survivors
The effect of lamivudine- versus tenofovir-containing antiretroviral regimen on hepatitis B infection in a cohort of HIV infected long term survivors Aura Temereanca 1,2, Luminita Ene 3, Adelina Rosca
More informationHarm reduction among drug users in Spain
Harm reduction among drug users in Spain Luxemburg,, 27 October 21 Dr. José Manuel Arroyo Cobo Deputy Director General of Health in Prisons Ministry of Internal Affairs Dr. Tomás s Hernández ndez Fernández
More informationHIV in Ireland 2016 Report
HIV in Ireland 2016 Report Acknowledgements In order to accurately track the HIV epidemic in Ireland and to assess the impact of HIV prevention programmes, it is essential to have good quality surveillance
More informationGlobal health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )
Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies
More informationPage 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions
Harvard-Brazil Collaborative Public Health Field Course January 2014 Lecture # 8 Building specialized knowledge: HIV Aluisio Segurado Department of Infectious Diseases School of Medicine, University of
More information2004 Update. Luxembourg
2004 Update Luxembourg 2 Luxembourg HIV/AIDS estimates In 2003 and during the first quarter of 2004, UNAIDS and WHO worked closely with national governments and research institutions to recalculate current
More informationAN EVALUATION OF HIV CASE-BASED SURVEILLANCE IN IRELAND: DESCRIPTION OF THE SYSTEM, SENSITIVITY AND TIMELINESS. November 2015
AN EVALUATION OF HIV CASE-BASED SURVEILLANCE IN IRELAND: DESCRIPTION OF THE SYSTEM, SENSITIVITY AND TIMELINESS November 2015 Authors: Coralie Giese, European Program for Intervention Epidemiology Training,
More informationState of Alabama HIV Surveillance 2013 Annual Report Finalized
State of Alabama HIV Surveillance 2013 Annual Report Finalized Prepared by: Division of STD Prevention and Control HIV Surveillance Branch Contact Person: Allison R. Smith, MPH Allison.Smith@adph.state.al.us
More information